heyzo中文字幕无码_亚洲天堂久久无码视频_国产性爱福利小视频_亚洲精品网站在线观看

中投顧問
中投顧問

24小時(shí)免費(fèi)服務(wù)熱線400-008-1522

Investment and Forecast Report on China Biopharmaceutical Industry, 2024-2028

首次出版:最新修訂:August 2012交付方式:特快專遞(2-3天送達(dá))

報(bào)告屬性:共0頁(yè)、70個(gè)圖表下載目錄 版權(quán)聲明

定購(gòu)電話:0755-82571522、82571566、400-008-1522

24小時(shí)服務(wù)熱線:138 0270 8576 定制報(bào)告

版本 在線版 電子版+印刷版 在線報(bào)告庫(kù)(超1000份報(bào)告)全庫(kù)
優(yōu)惠價(jià) RMB 6800 RMB 7800 RMB 9800
原價(jià) RMB 9600 RMB 9800 -

立即訂購(gòu) 加入購(gòu)物車 QQ咨詢 在線客服

限時(shí)特惠,降價(jià)還增量!

讓您輕松實(shí)現(xiàn)"讀報(bào)告自由"!

在線報(bào)告庫(kù)有超1000份報(bào)告,

全庫(kù)只需9800元,平均每份報(bào)告僅需9.8元!

查看千份報(bào)告清單 > 立即訂購(gòu)在線報(bào)告庫(kù) >

X

申請(qǐng)?jiān)囉?/h1>

請(qǐng)完善以下信息,我們顧問會(huì)在一個(gè)工作日內(nèi)與您聯(lián)系

*姓名

*手機(jī)號(hào)

*政府/園區(qū)/機(jī)構(gòu)/企業(yè)名稱

您的職務(wù)

您的郵箱

備注

立即申請(qǐng)

X

您的需求已經(jīng)提交!

如果您希望盡早試用體驗(yàn),也可以直接聯(lián)系我們。

聯(lián)系電話:   400 008 0586;   0755-82571568

微信掃碼:   掃碼咨詢

報(bào)告目錄內(nèi)容概述 定制報(bào)告

Chapter Ⅰ Summaries Related to Biopharmaceutical Industry
  1.1 Brief introduction of biopharmaceutical manufacturing concept
  1.2 Brief summary of biopharmaceutical industry
  1.3 Main products introduction of biopharmaceutical
  1.4 Different sources of biopharmaceutical
Chapter Ⅱ Development Analysis of International Biopharmaceutical
  2.1 General overview of international biopharmaceutical
  2.2 USA.
  2.3 Europe
  2.4 Singapore
  2.5 Other countries
Chapter Ⅲ Development of Biopharmaceutical Industry in China
  3.1 Development Environment of biopharmaceutical in China
  3.2 Development summary of biopharmaceutical industry in China
  3.3 Development of biopharmaceutical industry in China 2010
  3.4 Analysis of biopharmaceutical market in China 2011
  3.5 Development of biopharmaceutical industry in China 2011
  3.6 Analysis of biopharmaceutical industry cluster development in China
  3.7 Development problems of biopharmaceutical in China
  3.8 Development strategies of biopharmaceutical industry in China
Chapter Ⅳ Economic Operation Data Analysis of Biopharmaceutical in China
  4.1 Overall data analysis of biopharmaceutical enterprises in China 2010-2012 Jun.
  4.2 Data analysis of different ownership enterprises of biopharmaceutical industry in China 2011-2012 Jun.
  4.3 Data analysis of different scales enterprises of biopharmaceutical industry in China 2011-2012 Jun.
Chapter Ⅴ Blood products
  5.1 Analysis of blood products industry in China
  5.2 Problems existing in blood products industry in China
  5.3 Development strategies of blood products industry in China
  5.4 Prospect and investment risks analysis of blood products industry in China
Chapter Ⅵ Vaccine
  6.1 Development overview of global vaccine market
  6.2 Development of vaccine industry in China
  6.3 Overview of vaccine category management in China
  6.4 AIDS vaccine
  6.5 Flu vaccine
  6.6 Hepatitis B vaccine
  6.7 Cancer vaccine
Chapter Ⅶ Genetic Engineering Drugs
  7.1 Development analysis of international genetic engineering drugs
  7.2 Development of genetic engineering drugs in China
  7.3 Analysis of genetic engineering drugs industrialization in China
  7.4 Development strategies and trend of genetic engineering drugs in China
Chapter Ⅷ Antibody Engineering Drugs
  8.1 Development analysis of antibody engineering drugs
  8.2 Development of monoclonal antibody drugs
  8.3 Development of antibody engineering drugs technology
Chapter Ⅸ Diagnostic Reagents
  9.1 Overview related to diagnostic reagents
  9.2 Development of diagnostic reagents market in China
  9.3 Development trend of diagnostic reagents in China
Chapter Ⅹ Development of Biopharmaceutical in Main Areas of China
  10.1 Shandong Province
  10.2 Zhejiang Province
  10.3 Jiangsu Province
  10.4 Guangdong Province
  10.5 Hubei Province
  10.6 City of Shanghai
Chapter Ⅺ Foreign Key Listed Enterprises
  11.1 AMGEN
  11.2 GENENTECH
  11.3 BIOGEN IDEC
  11.4 GENZYME
Chapter Ⅻ Domestic Key Listed Enterprises
  12.1 Sino Biopharmaceutical Co., Ltd.
  12.2 Unisplendour Guhan Group Co., Ltd.
  12.3 Beijing Tiantan Biological Products Co., Ltd.
  12.4 Shenzhen Neptunus Bioengineering Co., Ltd.
  12.5 Ginwa Enterprise (Group) Co., Ltd.
  12.6 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  12.7 Hualan Biological Engineering Inc.
  12.8 Shanghai Kehua Bio-engineering Co., Ltd.
  12.9 Da An Gene Co.,Ltd. Of SUN YAT-SEN University
  12.10 Shenzhen CAU Technology Co.,Ltd.
Chapter ⅩⅢ Analysis of Competition Situation of Biopharmaceutical in China
  13.1 Competition overview of medicine industry in China
  13.2 Analysis of competition features of biopharmaceutical in China
  13.3 Analysis of competition structure of biopharmaceutical in China
  13.4 Suggestions for improving competitiveness of biopharmaceutical in China
Chapter ⅩⅣ Investment Analysis
  14.1 Investment opportunities
  14.2 Investment analysis of biopharmaceutical in China under the financial crisis
  14.3 Financing analysis of biopharmaceutical enterprises in China
  14.4 Evaluation analysis of venture capital projects of biomedical
  14.5 Investment risk analysis of biopharmaceutical industry in China
  14.6 Investment suggestions
Chapter ⅩⅤ Prospect and Trend of Biopharmaceutical Industry in China
  15.1 Prospect and trend of international biopharmaceutical industry
  15.2 Prospect and trend of biopharmaceutical industry in China

圖表目錄
圖表目錄請(qǐng)咨詢客服
本報(bào)告目錄與內(nèi)容系中投顧問原創(chuàng),未經(jīng)中投顧問書面許可及授權(quán),拒絕任何形式的復(fù)制、轉(zhuǎn)載,謝謝!

如果報(bào)告內(nèi)容未能滿足您的需求,請(qǐng)了解我們的報(bào)告定制服務(wù)>>

Investment and Forecast Report on China Biopharmaceutical Industry, 2024-2028

    中投影響力

    資質(zhì)榮譽(yù) 媒體合作 公司動(dòng)態(tài)

    外商投資企業(yè)協(xié)會(huì)會(huì)員單位外商投資企業(yè)協(xié)會(huì)會(huì)員單位

    最具品牌價(jià)值行業(yè)門戶最具品牌價(jià)值行業(yè)門戶

    發(fā)改委十佳創(chuàng)新案例金典獎(jiǎng)發(fā)改委十佳創(chuàng)新案例金典獎(jiǎng)

    電子行業(yè)協(xié)會(huì)副會(huì)長(zhǎng)單位電子行業(yè)協(xié)會(huì)副會(huì)長(zhǎng)單位

    哈爾濱最佳項(xiàng)目策劃智庫(kù)單位哈爾濱最佳項(xiàng)目策劃智庫(kù)單位

    深圳市商業(yè)聯(lián)合會(huì)會(huì)員單位深圳市商業(yè)聯(lián)合會(huì)會(huì)員單位

    珠海招商合伙人珠海招商合伙人

    重慶市產(chǎn)業(yè)招商聯(lián)盟單位重慶市產(chǎn)業(yè)招商聯(lián)盟單位

    中投顧問協(xié)辦的濟(jì)陽(yáng)區(qū)(深圳) "新能源汽車產(chǎn)業(yè)"專題推介會(huì)中投顧問協(xié)辦的濟(jì)陽(yáng)區(qū)(深圳) "新能源汽車產(chǎn)業(yè)"專題推介會(huì)

    中投顧問受邀為合肥市投促部門作機(jī)器人產(chǎn)業(yè)招商培訓(xùn)中投顧問受邀為合肥市投促部門作機(jī)器人產(chǎn)業(yè)招商培訓(xùn)

    中投顧問為珠海全市招商系統(tǒng)培訓(xùn)產(chǎn)業(yè)招商大腦獲得圓滿成功中投顧問為珠海全市招商系統(tǒng)培訓(xùn)產(chǎn)業(yè)招商大腦獲得圓滿成功

    中投顧問為漢中市作"大數(shù)據(jù)招商、精準(zhǔn)招商"培訓(xùn)中投顧問為漢中市作"大數(shù)據(jù)招商、精準(zhǔn)招商"培訓(xùn)

    中投顧問項(xiàng)目組赴安慶迎江經(jīng)開區(qū)調(diào)研中投顧問項(xiàng)目組赴安慶迎江經(jīng)開區(qū)調(diào)研

    湖州市吳興區(qū)駐深辦來(lái)訪中投顧問湖州市吳興區(qū)駐深辦來(lái)訪中投顧問

    河北邢臺(tái)南宮市駐深領(lǐng)導(dǎo)赴中投顧問拜訪河北邢臺(tái)南宮市駐深領(lǐng)導(dǎo)赴中投顧問拜訪

    中投顧問陪同廣州某經(jīng)開區(qū)領(lǐng)導(dǎo)赴外商協(xié)會(huì)治談合作中投顧問陪同廣州某經(jīng)開區(qū)領(lǐng)導(dǎo)赴外商協(xié)會(huì)治談合作

    微信掃一掃關(guān)注公眾號(hào)"中投顧問"(ID :touziocn),回復(fù)""即可獲取。

    知道了
    QQ咨詢
    在線客服